OBJECTIVES: To assess the influence of region of interest (ROI) size and positioning on tumour ADC measurements and interobserver variability in patients with locally advanced rectal cancer (LARC). METHODS: Forty-six LARC patients were retrospectively included. Patients underwent MRI including DWI (b0,500,1000) before and 6-8 weeks after chemoradiation (CRT). Two readers measured mean tumour ADCs (pre- and post-CRT) according to three ROI protocols: whole-volume, single-slice or small solid samples. The three protocols were compared for differences in ADC, SD and interobserver variability (measured as the intraclass correlation coefficient; ICC). RESULTS: ICC for the whole-volume ROIs was excellent (0.91) pre-CRT versus good (0.66) post-CRT. ICCs were 0.53 and 0.42 for the single-slice ROIs versus 0.60 and 0.65 for the sample ROIs. Pre-CRT ADCs for the sample ROIs were significantly lower than for the whole-volume or single-slice ROIs. Post-CRT there were no significant differences between the whole-volume ROIs and the single-slice or sample ROIs, respectively. The SDs for the whole-volume and single-slice ROIs were significantly larger than for the sample ROIs. CONCLUSIONS: ROI size and positioning have a considerable influence on tumour ADC values and interobserver variability. Interobserver variability is worse after CRT. ADCs obtained from the whole tumour volume provide the most reproducible results. Key Points * ROI size and positioning influence tumour ADC measurements in rectal cancer * ROI size and positioning influence interobserver variability of tumour ADC measurements * ADC measurements of the whole tumour volume provide the most reproducible results * Tumour ADC measurements are more reproducible before, rather than after, chemoradiation treatment * Variations caused by ROI size and positioning should be taken into account when using ADC as a biomarker for tumour response.
- Diffusion magnetic resonance imaging
- Rectal neoplasms
- Observer variation
- Apparent diffusion coefficient
- APPARENT DIFFUSION-COEFFICIENT
- CHEMORADIATION THERAPY
- IMAGING BIOMARKER